Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
An intensive transition navigator intervention improves transition readiness to adult care in youth with sickle cell disease
source: American Society of Hematology
year: 2017
authors: Deepa Manwani, Lynn Davidson, Ellen Silver, Rosy Chhabra, Caterina Minniti, Deepa Rastogi, Maya Doyle, Kerry A Morrone, Ruth Stein, Suzette Oyeku, and Laurie Bauman
summary/abstract:Introduction: Transition to adult care is a high-risk period with increased health care utilization and death in Sickle Cell Disease (SCD) patients (Brousseau 2010, Hemker BG 2011, Paulukonis ST 2016), as in other chronic illnesses. Lack of transition planning may result in poor quality of care; low patient satisfaction; and avoidable morbidity, ED visits, hospitalizations and mortality. The American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP) and American College of Physicians (ACP) issued joint recommendations describing steps to assure effective transition, however, few pediatric hematology practices follow these recommendations. Use of a dedicated transition navigator (TN) from pediatric to adult care has been successful in other chronic illnesses such as congenital heart disease and diabetes. (Mackie 2016) We report on changes in transition readiness following an intensive TN intervention delivered to youth 17-20 years old over a period of 6-12 months at an urban academic medical center.
Methods: We developed and implemented a protocolized intervention for young adults with SCD, aged 17-20 years, delivered by a trained TN with 5 goals: (1) an individualized transition plan; (2) a portable medical summary (Transition Passport); (3) improve patient knowledge and skills for self-management of SCD to address quality of care, adherence, and proper use of the ED; (4) address family members’ roles in transition; and (5) facilitate transfer to an adult provider. Youth completed self-administered surveys at enrollment and program completion including the 20-item Transition Readiness Assessment Questionnaire (TRAQ) and measures of SCD knowledge, confidence in disease management, and use of an appropriate pain management plan. Pre/post scores were compared using paired t-tests. Satisfaction with the TN intervention was assessed at program completion.
Conclusion: A TN program is acceptable to youth with SCD and feasible to implement at an urban academic medical center. Our data demonstrate that participation in the TN program is associated with improved transition readiness and disease knowledge for youth with SCD. Further study is needed to determine if this intervention improves transfer to adult care and reduces morbidity.
organization: Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NYread more
+myBinderRelated Content
-
Andra James, MD, MPHDr. James is an OB-GYN consultant and a ...
-
Children’s Healthcare of Atlanta Sickle Cell Disease ProgramChildren's Healthcare of Atlanta's Sickl...
-
Hassenfeld Children’s Hospital at NYU LangoneHassenfeld Children’s Hospital at NYU ...
-
SCDAI’S 19th Annual Golf OutingIn 2021, we are celebrating 50 years as ...
-
Sickle Cell Disease Association of America, Inc., the Sickle Cell Foundation of Georgia, Inc., and the American Red ...The Sickle Cell Disease Associ...
-
Stigmatizing language in medical records affects patient care, study showsPhysicians who use stigmatizing langua...
-
Higher Executive Abilities Following a Blood Transfusion in Children and Young Adults With Sickle Cell DiseaseIndividuals with sickle cell disease (SC...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.